Status:
UNKNOWN
Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients
Lead Sponsor:
Shenzhen People's Hospital
Conditions:
Acute ST-segment Elevation Myocardial Infarction
Radial Artery Occlusion
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The transradial access (TRA) is currently the preferred approach for percutaneous coronary intervention (PCI). However, in patients with ACUTE ST-segment elevation myocardial infarction (STEMI) after ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of STEMI
- To undergo emergency PCI treatment
- Palpable pulsation of the radial artery and distal radial artery
Exclusion
- Arteriovenous fistula of radial artery and cephalic vein has been performed with regular hemodialysis
- Suspicious left main block of electrocardiogram
- Had used the radial artery percutaneous interventional treatment before
- Cardiogenic shock
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2022
Estimated Enrollment :
414 Patients enrolled
Trial Details
Trial ID
NCT04861389
Start Date
January 1 2021
End Date
January 31 2022
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzhen People's Hospital
Shenzhen, Guangdong, China, 518020